Extracorporeal shockwave therapy

src: draaroncase.com

Extracorporeal shock wave therapy ( ESWT ) is a treatment mostly used to treat kidney stones and physical and orthopedic therapies.

Video Extracorporeal shockwave therapy

Medical use

The most common use of extracorporeal shock therapy (ESWT) is for lithotripsy to treat kidney stones (urinary calculations) and biliary calculi (stones in the gallbladder or in the liver) using acoustic pulses. It is also reportedly used for saliva and pancreatic stones.

In the UK, NICE has found that evidence for ESWT in most of the indications is contradictory, since the ESWT should only be used if there are specific settings for clinical and audit governance. Two 2017 reviews have similar findings, with the best mid-level evidence.

Extracorporeal shock wave therapy is used as a second line measurement to treat tennis elbow, rotator shoulder rotator pain, achilles tendinitis, plantar fasciitis, and greater trochantic pain syndrome.

ESWT is also used to promote bone healing and treat bone necrosis. This is an effective alternative to non-healing fracture surgical treatment.

ESWT is used for wound healing and has shown positive results in short and long term outcomes in diabetic patients with foot ulcers. A randomized controlled trial into the use of ESWT for healing venous ulcers is necessary because there is a lack of evidence in this area.

Maps Extracorporeal shockwave therapy

Procedures

The lithotriptor tries to break rocks with minimal collateral damage by using externally applied, focused, and high intensity acoustic pulses. Patients are usually anesthetized or anesthetized for procedures to help them keep silent and reduce the possibility of discomfort.

src: nnimgt-a.akamaihd.net

History

Beginning in 1969 and funded by the German Ministry of Defense, Dornier began his study of the effects of shock waves on the network. In 1972, on the basis of a preliminary study conducted by Dornier Medical Systems, an agreement was reached with Egbert Schmiedt, director of urology clinics at the University of Munich. The development of Dornier lithotripter evolved through several prototypes, which eventually culminated in February 1980 with the first human treatment by SWL. Production and distribution of DHM3 lithotripter HM3 began in late 1983, and SWL was approved by US Food and Drug. Administration in 1984.

In the 1980s people who used ESWT for kidney stones realized that it appeared to increase bone density in nearby bones, leading them to explore it for orthopedic purposes.

src: bjsm.bmj.com

Research

In response to concerns raised by NICE, in 2012 a study called ESWT Effectiveness Assessment for Software Network Injury was launched.

By 2018 the use of ESWT has been studied as a potential treatment for chronic prostatitis/chronic pelvic pain syndrome in three small studies; there are short-term improvements in symptoms and some side effects, but medium-term outcomes are unknown, and the results are difficult to generalize because of the low quality of the study.

src: thumbs.dreamstime.com

Veterinary use

ESWT is commonly used to treat orthopedic problems in horses, including tendon and ligament injuries, kissing of the spine, navicular syndrome, and arthritis. The evidence for this usage is weak.

src: www.physiotherapyvictoria.ca

See also

• Laser lithotripsy

src: i.ytimg.com

References

Source of the article : Wikipedia